SPPI Spectrum Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SPPI

Price (delayed)

$0.67

Market cap

$136.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$108.38M

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business ...

Highlights
The company's EPS rose by 41% YoY and by 13% QoQ
SPPI's net income is up by 33% YoY and by 10% QoQ
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 7% QoQ
The quick ratio rose by 22% QoQ but it fell by 15% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.sppirx.com
Peers: TEVA SGEN CRIS ABT

Key stats

What are the main financial stats of SPPI
Market
Shares outstanding
203.21M
Market cap
$136.15M
Enterprise value
$108.38M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.52
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$106.09M
EBITDA
-$104.8M
Free cash flow
-$102.12M
Per share
EPS
-$0.62
Free cash flow per share
-$0.54
Book value per share
$0.19
Revenue per share
$0
TBVPS
$0.63
Balance sheet
Total assets
$118.93M
Total liabilities
$83.08M
Debt
$28.49M
Equity
$35.85M
Working capital
$63.36M
Liquidity
Debt to equity
0.79
Current ratio
2.28
Quick ratio
2.03
Net debt/EBITDA
0.26
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-103.6%
Return on equity
-246.7%
Return on invested capital
-6,671.3%
Return on capital employed
-153.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SPPI stock price

How has the Spectrum Pharmaceuticals stock price performed over time
Intraday
-5.98%
1 week
-18.11%
1 month
-8.22%
1 year
-50.37%
YTD
81.82%
QTD
81.82%

Financial performance

How have Spectrum Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$97.91M
Net income
-$106.13M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 44% YoY and by 11% from the previous quarter
SPPI's net income is up by 33% YoY and by 10% QoQ

Growth

What is Spectrum Pharmaceuticals's growth rate over time

Valuation

What is Spectrum Pharmaceuticals stock price valuation
P/E
N/A
P/B
3.52
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 41% YoY and by 13% QoQ
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 7% QoQ
SPPI's price to book (P/B) is 12% lower than its 5-year quarterly average of 4.0 and 4.9% lower than its last 4 quarters average of 3.7

Efficiency

How efficient is Spectrum Pharmaceuticals business performance
The return on equity has dropped by 73% year-on-year and by 13% since the previous quarter
Spectrum Pharmaceuticals's return on assets has decreased by 14% YoY but it has increased by 3.1% QoQ

Dividends

What is SPPI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SPPI.

Financial health

How did Spectrum Pharmaceuticals financials performed over time
Spectrum Pharmaceuticals's total assets is 43% higher than its total liabilities
SPPI's total liabilities has surged by 81% since the previous quarter and by 22% year-on-year
Spectrum Pharmaceuticals's total assets has increased by 50% QoQ but it has decreased by 20% YoY
Spectrum Pharmaceuticals's debt is 21% less than its equity
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.